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Tumors are one of the most common reasons of morbidity and mortality.
In Russian  Federation  were  registered  640391[1]  incidence  of  malignant
neoplasms in 2019, that bigger on 2.5 % than in 2018 and 30.4 % than in 2009.
Some of reasons of tumor appearance are well studied, that allow to prevent
not less that 1/3 of all incidence of disease. On other hand, medicine has big amount
treatment  ways  of  cancer  patients.  One  of  them  is  radiation  therapy  based  on
treatment of malignant neoplasm with ionizing radiation.
Tumor of head-and-neck region are not the most common, however treatment
of  neoplasm  in  such  localization  with  radiation  therapy  is  complicated  by  some
parameters:
- Side  effects:  early  reactions  to  radiation  occur  in  the  first  weeks  and
continue for  some time after  the course  of  radiation therapy.  Side  effects  always
causes  at  least  discomfort,  but  given  that  some  of  them  are  visually  noticeable
(including erythema), because they are in a visible place, some patients are not ready
to finish such a course of therapy.
- Rate of cell division and growth: head-and-neck tumors are mainly rapidly
growing.  Thereby any delays or interruptions in treatment have especially negative
effect on the result of treatment.
- Localization: head-and-neck region is the most important area of the human
body, containing a complex of organs that perform a wide range of functions, which
requires careful planning in order to exclude organs from the radiation area or reduce
the dose to adjacent tissues.
- Tumor  control:  90 %  of  all  head  and  neck  tumors  are  radiosensitive
squamous cell  carcinoma,  that  is  a  type of  tumor that  responds well  to  radiation
treatment. However, despite the fact that the size of such tumors changes rapidly with
a change in the dose (total and/or dose per fraction), the dependence of the tumor
response on the dose is ambiguous.
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Therefore  drawing  up  a  treatment  plan  for  radiation  therapy  means  the
development of more than one irradiation method for further analysis of the choice of
a more optimal solution. One of the factors in evaluating a treatment plan  are the
tumor control probability (TCP), normal tissue complications probability(NTCP) and
their combination, determining probability of damaging tumor by irradiation without
harm to healthy tissue. Both mentioned parameters depends on equivalent uniform
dose (EUD), the absorbed dose if it homogeneously distributed in the tumor, which
defined through the dose distribution, volume received specific dose and parameter
describing  tissue  behavior  on  irradiation.  Evaluation  of  the  plan  implies  the
prediction of  expected outcomes,  and since  dose value is  directly  correlated with
results of treatment, the EUD concept can be used to analyze treatment plans.
The relevance of the work is the need to improve the quality of treatment for
patients with advanced stages of head-and-neck tumors receiving radiation therapy.
Goal of work: evaluation of effectivity of implemented treatment of malignant
neoplasms in head-and-neck region with radiation therapy and prediction possible
treatment results. 
Tasks:
- Literature review of the different radiation therapy treatment regimens in
head-and-neck region tumors.
- Estimation of head-and-neck tumor radiological parameters such as  TD50
and γ50 based on literature review. 
- Development of software for calculation of equivalent uniform dose (EUD),
tumor  control  probability  (TCP),  normal  tissue  complication  probability  (NTCP),
plotting mentioned parameters and dose-volume histogram (DVH).




1.1 Radiobiological basis of radiation therapy
Radiation therapy (radiotherapy) is a cancer treatment that uses high doses of
ionizing radiation to kill cancer cells and shrink tumors.
Action  of  ionizing  radiation on  biological  object  can  be  separated  on  3
temporary stages: physical, chemical and biological (figure 1). 
Figure 1 – Time scale of processes, induced in biological systems after irradiation of IR [2]
Physical stage includes interaction of radiation with atoms of tissue. Moving
in medium, photon mostly transmits energy to orbital electrons. In result, electrons or
fly  out  from  atom,  either  move  on  higher  level  inside  of  atom  (excitation  of
molecules). If electrons have enough energy, they start to ionize other atoms [2]. 
Chemical  stage include process,  in  which excited and ionized atoms react
with other components of cell in fast chemical reactions. It leads to breaking down
chemical links and formation of non-stable molecules, free radicals [3], which react
with neighboring molecules due to which the composition of medium changes. 
Biological  stage starts  from enzymatic reactions which influence on saved
chemical damages. The most part of damages successfully repairs. Some reparation
are not successful enough that leads to cell death [2]. 
The main types of structural radiation damages (figure 2):
1. single DNA breaks, breaking one DNA strand;
2. double-stranded DNA breaks, the coincidence of breaks at opposite DNA
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strands;
3. violation of the DNA-protein bond;
4. damage to the structure of the DNA membrane complex;
5. destruction of nuclear membranes;
6. damage to the mitochondrial membrane;
7. damage to the cytoplasmic membrane [2].
Figure 2 – The main type of structural radiation damages:
1 –single DNA breaks, 2 – double-stranded breaks of DNA, 3 – violation of the DNA-protein bond,
4 – damage to the structure of the DNA membrane complex, 5 – destruction of nuclear membranes,
6 – damage to the mitochondrial membrane, 7 – damage to the cytoplasmic membrane 
According  to  this,  the  most  vulnerable  cell  part  to  radiation  damaging  is
DNA.
1.2 Linear-quadratic model (LQ-model)
After  irradiation the cells  do not  perish  immediately,  but  after  reaching a
sufficient number of non-fatal injuries that accumulate with each subsequent division,
the cells lose their ability to divide and perish.  For experiments  in vitro If  a  cell
creates less than 50 of its own during division, it is considered that the cell has died.
In a living organism, there is no way to count the exact number of cells and their
descendants.  The  proportion  of  surviving  cells  after  irradiation  is  called  clonal
survival. 
For quantitative description of cell death, the most common model is linear-
quadratic model (LQ-model)[2] shown on Figure 3:
SF=exp (−α⋅D− β⋅D2 ) , (1)
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where SF is surviving fraction, i.e. number of survival cells;
D is the radiation dose, Gy;
α,β is  empirical coefficients specific for each organ or tissue, Gy-1 and Gy-2
respectively.
Figure 3– Typical view of the survival curve: A – linear scale, B – semi logarithmic scale [2]
Equation  for  LQ-model  taking  into  account  fractionation  in  radiation
therapy[4]:
SF (D)=e−n (α d+βd
2
) , (2)
where n is a number of fractions;
d is fraction dose (single dose of radiation ), Gy.
For  taking  into  account  treatment  time  which  directly  correlate  with  cell
repopulation, additional exponential factor was introduced [4]: 




SF (D)=e−n (αd+β d
2
)+λ (t−t0 ) ,
(3)
Where λ is proportionality factor determined experimentally;
t0 is time delay (if tumor repopulation begins after some time delay);
t is time since therapy started ( t ≥ t0 ).
1.3 Fractionation in radiation therapy 
Treatment of radiation therapy consists of high total dose which delivered by
portion spread during all treatment time (except stereotactic radiosurgery (SRS). Such
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single dose called fraction.
The  reason  for  using  this  method  is  the  different  radiosensitivity  of  the
irradiated  cells,  as  well  as  the  repair  of  normal  cells,  which  takes  time.
Radiosensitivity can change during few hours that connects with stage of cell cycle:
whole cycle of cell division takes about 10 – 24 hours, cell has the highest sensitivity
in last stage due to DNA vulnerabilities. Moreover cell has mechanism for reparation
that stop cell cycle if specific enzymes notice some violations. Thereby normal cells
should have some time to repair induced damages and become normal functional cell
again. 
The initial radiation therapy was based on low energy with a significantly low
penetrating power. Until 1950, remote radiation therapy was performed mainly using
X-rays generated by a maximum of 300 kV. In the 1950s and 1960s, existing kV
machines were gradually replaced by high-energy machines, as the development of
high-energy photon-emitting accelerators and Co-60 therapy machines became very
popular[5]. For Co-60 therapy machine  with square irradiation field dose delivery
limit  is  2 Gy  per  fraction,  therefore,  1.8  –  2  Gy  was  taken  as  the  classical
(conventional)  fractionation  mode.  The  duration  of  treatment  for  the  classic
fractionation mode usually ranges from 4 to 7 weeks.
Also there are treatment methods that short treatment time with increasing
total dose per day. Some of them call hyperfractionated. In this case, radiation can be
delivered more than one time per day with dose 1 – 1.5 Gy. The radiobiological basis
of its application is that most tumors are rapidly proliferating tissue, and summing up
several small fractions per day allows healthy tissues to recover while maintaining a
highly effective effect on the tumor [6]. Dose per fraction can be increased to 2 Gy if
patient  irradiates  no  more  than  2  times  a  day,  this  fractionation  method  calls
accelerated radiation therapy. 
On the other hand, there are irradiation mode which also leads to decreasing
treatment  time but  consisting  in  increasing dose  per  fraction.  In  hypofractionated
radiation therapy dose 3 Gy or more can be delivered to patients 3 – 4 times per
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week. Radiobiological prerequisites for the use of this method are the prevention of
accelerated depopulation during treatment by reducing the duration of exposure.
In additional, for all methods of radiation therapy boost, i.e. local irradiation
of tumor, can be used.  Given to the area at highest risk for cancer recurrence doost
increases the amount of radiation. There are two types of boost which used:
- sequential boost (SEQ), this type of boost delivery consists of sequential
irradiation two and more volumes. For examples, lymph nodes should have smaller
dose than primary part of target (tumor) and, in this case, after all fractions of lymph
nodes irradiation an additional fractions will deliver prescribed dose to the tumor;
- simultaneous integrated boost (SIB), modern type of dose delivery which
consists of dose escalation in area of interest simultaneously with irradiation of other
volume. It means that while one session lymph nodes should get one fractionated
dose, tumor will receive another.
According to researches noticed in article [7], SIB has advantages over SEQ
especially  for  fast-growth  tumors  due  to  decreasing  duration  of  whole  treatment
course.
1.4 Radiation therapy techniques
Before irradiation, the contour of the tumor and surrounding tissues,  called
critical  organs  or  organs  at  risk  (OARs),  must  be  determined.  For  this  purpose
diagnostic  scans  are  usually  used.  It  can  be  data  from  computed  tomography,
magnetic-resonance imaging or positron-emission tomography. 
Special treatment system planning is used in radiotherapy for delineation and
planning. Companies that produce their own equipment provide a planning system
for  it.  The  most  common companies  producing  radiation  therapy  equipment  and
software for them are Elekta and Varian. Now Elekta support only Monaco system,
which mostly suitable for IMRT and VMAT, for Varian it is Eclipse system. Figure 4
shows example of head-and-neck region delineation in Monaco system.
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Figure 4– Example of head-and-neck region delineation.
After  delineation  patient  should  be  positioned  on  the  couch  in  the  same
position as in CT scans for further dose delivery.
Four types of radiation therapy techniques here are considered:
- conventional radiotherapy;
- conformal radiotherapy;
- intensity-modulated radiation therapy;
- volumetric modulated arc therapy.
Conventional radiotherapy is the oldest techniques for dose delivery, which
implies using only of jaws of gantry for shaping where jaws are simply represented as
two metal blocks. It means that irradiation field can be only either square or rectangle
form  that  leads  to  big  dose  load  on  OARs.  For  delineation  in  this  case  planar
radiograph or limited CT data were used. 
With advances of opportunities in software and radiation therapy equipment,
it became possible to treat the tumor more precisely while preventing of irradiation of
healthy surrounding tissue. In conformal radiation therapy (3D CRT) the shape of
each beam, field, determines using an multileaf collimator (MLC) which allow to
match the shape of the target. When the treatment volume corresponds to the shape of
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the tumor, the relative radiation toxicity to surrounding normal tissues is reduced
because the largest share of dose is located in tumor area, that allows to deliver a
higher dose of radiation to target. Figure 5 shows example of MLC. 
Figure 5 – Example of MLC: A – schematic representation, B – real view
Moreover, it became possible to use non - coplanar beams and 3D planning
(volumetric calculations) with 3D visualization due to ability to reconstruct model of
interest. 
The next stage of progress is intensity-modulated radiation therapy (IMRT)
which allows to work with the irregular shape of the tumor and change intensity of
beam when volume is irradiated while reducing the burden on healthy tissues and
delivering  radiation  to  the  tumor  with  greater  accuracy.  Figure  6 represents
comparative analyzes for three mentioned radiation techniques. 
Figure 6 – Dose distribution for three types of radiation techniques [8]: value of dose increase from
blue to yellow color
Volumetric  modulated  arc  therapy  (VMAT)  implies  continuously  rotation
around  the  patient  during  irradiation.  It  also  uses  MLC as  3D CRT and  IMRT,
VMAT can change dose rate while irradiated as IMRT but, in this case, every second
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while  rotates  and  can  optimize  speed  of  each  beam  rotation.  The  radiation  is
delivered to the intended area, allowing to spare more surrounding healthy tissue.
Treatment time for VMAT is significantly shorter, thus benefits patients who require
longer (30 minutes or more) treatment time. 
Using  VMAT  implies  creating  arcs,  i.e.  designation  of  the  trajectory  of
movement of the gantry around the isocenter. The number of arcs and their length is
determined by the area of irradiation, the stage of the disease, as well as the desired
dose distribution.
For  3D  CRT,  IMRT  and  VMAT  immobilization  devices  are  of  great
importance due to precise dose delivery ( increased precise of delivery requires more
accuracy in positioning): it is necessary to minimizing positioning errors and do not
over-irradiate normal tissues. The main task of positioning is the alignment of the
isocenter of the patient during the current position and during the acquisition of CT
scans. For immobilization, thermoplastic masks and holders (figure  7) are specially
made for different parts of the body in compliance with individual anatomy, special
mattresses that remember the previous position of the patient, and additional blocks
and clamps can also be used. 
Figure 7 – Example of immobilization device: A – SBRT base plate with rolls ans wedges; B –
invasive head frame; C – individual thermoplastic mask; D – vacuum mattress; E – thermoplastic
holder for pelvis region
Irradiation  and  non  irradiation  systems  of  image-guided  radiation  therapy
(IGRT) are used to check the position of  the isocentre, as well as to account for
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breath and other movements that affect the position of the isocentre. Figure 8 shows
typical assembly of a modern linear accelerator with cone beam CT which used x-ray
for CT image acquisition during treatment. 
Figure 8 – Typical assembly of a modern linear accelerator with cone beam CT: A – MV-irradiation
source, b- – digital MV-image converter to check patient position with the treatment beam, 
C – kV-x-ray generator, D – kV-image converter to acquire CT-data.
For 3D CRT and conventional radiotherapy medical physicist set beams, dose
value and size of field by himself. For IMRT and VMAT inverse planning is used. In
this case, for each given angle (beam or arc) dose will be calculated with treatment
planning systems  based  on such  set  parameters  as  cost  functions.  Cost  functions
impose  certain  restrictions  or  set  goals  that  must  be  achieved  in  the  course  of
treatment. for example, 95% of the planned irradiated volume should be covered by
95% of the prescribed dose, but no more than 2% exceeding 107% of the prescribed
dose. For organs at risk, restrictions are imposed on the size of the dose and/or the
volume of the structure.
3D CRT is obviously inferior in quality of treatment to IMRT and VMAT,
but which of the two is the most preferred method is still a matter of debate. Figure 9
shows example of both techniques. 
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Figure 9 – Example of IMRT and VMAT for head-and-neck region
When  choosing  between  irradiation  methods,  it  is  necessary  to  take  into
account the great capabilities of VMAT in setting cost functions and their parameters.
In VMAT a lot is determined by the selected set of parameter in cost fucntions, while
IMRT  depends  more  on  the  choice  of  the  direction  of  the  gantry.  It  is  worth
emphasizing that VMAT implies continuous irradiation, i.e. when moving along a
trajectory, the gantry irradiates not only the tumor, but also the adjacent tissues along
the arc, while IMRT irradiates only in specific fixed positions. The most important
criterion for choosing a particular method is the irradiation area: localization, size,
inclusion of adjacent structures in tumor growth [9, 10, 11, 12].
At the end of planning software calculates dose values for each volume point,
voxel, and represents results not only in way of dose distribution on delineated CT
slices, but also as dependence volume on dose, that is called dose-volume histogram. 
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2 Dose-volume histogram (DVH)
In three-dimensional planning the exposure plan represent three-dimensional
massive of dose values in voxels, distributing in planing target volume of patient. To
analyze this number of points (the number of which can reach several  thousand),
dose-volume  histograms  (DVH)  are  widely  used.  This  plot  allows  to  summarize
information consisting of three-dimensional distributions, and serves as a powerful
resource for quantifying the treatment plan[2].
In simplest form DVH is frequency distribution of doses values inside the
volume. Instead of frequency the “percentage of total volume” usually uses.  This
value is the ordinate axis, and the dose is the abscissa axis. On practice two types of
DVH usually use(figure 10):
- differential DVH;
- cumulative DVH.
Disadvantage of DVH is loss of spatial information about dose distribution.
DVH calculate for target volume (tumor) and for OARs (figure 10).
Figure 10 – Differential and cumulative histogram dose-volume: red line – target volume, 
blue line – OAR
While creating differential DVH (DVHd) the numbers of voxels with average
dose inside choosing range are summarized. DVHd shows the dependence of volume
percent of the total body dose. DVHd for target volume look like column showing
that almost all volume of target received a dose in the range of which is prescribed.
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For critical  structure DVH can have  several  peaks,  indicating that  part  of  organs
received different doses. In ideal case it should be narrow peak for target and 0 Gy
for critical organ.
Cumulative DVH (DVHc) uses often than differential, because it allows to
determine to dose, which receive the biggest part (95%) of volume.
While creating cumulative DVH the program calculate  the value of  target
volume, which received dose less or equal to set value. Ideal cumulative DVH for
target volume has Heaviside function form (step), for critical organ is the straight line
equal to 0% volume on all range of dose.
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3 Equivalent uniform dose (EUD) concept
3.1 Normal tissue structural organization
In radiotherapy concept of serial and parallel architecture of organs is used.
The  architecture  has  a  strong  impact  on  the  tolerance  to  radiotherapy.  Figure 11
shows simplest representation of structure organization for this concept. 
Figure 11 – Normal tissue structural organization:
a – normal structure organization, b – damaging of sub-unit in structure
According to this it can be assumed that for organs with parallel organization
sub-units work independently from each other. It means that damage of one sub-unit
do not leads to failure of a whole organ but damaging of some numbers sub-units can.
For such organs it is necessary to set limits for “number” of such sub-units which can
create severe side effects and thereby protocol QUANTEC (Quantitative Analyses of
Normal  Tissue  Effects)  [13]  recommends  to  restrict  a  value  of  irradiated  organ
volume.
On  other  hand,  when  one  sub-unit  of  organ  with  serial  organization  had
damage whole organ will failure. Such organs work as conveyor where dysfunction
of previous step causes the current step to fail. For such organs QUANTEC set others
recommendations not to exceed the dose.
Both architectures, serial and parallel, are sometimes combined in the same
organ,  because  different  tissues  cooperate  to  a  common  function.  The  lung,  for
example, has a parallel architecture at the level of parenchyma where gas exchanges
take place. On the other hand, airways carrying air in and out of the alveoli have a
serial arrangement.
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3.2 Side effects of radiation therapy
Induced in biological phase depending on time of appearance radiation effects
can be divide on early (damaging of hematopoetic organs, suppuration of skin) and
late side effects (cancerogenesis, fibrosis). Time scale of observing effects spreads on
many years. 
The reason of  such  side  effects  is  irradiation  not  only  area  of  tumor,  but
normal organs situated near. Based on this, a treatment plan should be drawn up in
such  a  way  as  to  cause  the  greatest  harm  to  the  tumor  while  minimizing
complications for normal organs.
3.3 Volume effect
It  is  a  common radiotherapeutic  perception  that  the  severity  of  acute  and
chronic side effects increases as the volume of normal tissue irradiated is increased.
In radiobiological studies, the volume effect is defined by the relationship between
the radiation doses that cause the same probability of a certain acute or late normal
tissue  damage  and  the  irradiated  proportion  or  the  irradiated  volume  of  the
investigated tissue or organ.
The situation is complicated when several different organs are located in the
area of radiation (for example, the area near the renal pelvis). Then the volume effect
depends  on  the  probability  of  complications,  which,  in  turn,  depends  on  the
proportion of each organ in the high dose area The serial type of tissues will show a
significantly steeper dependence than the parallel type. In addition, it is noted that the
concept of complications is determined not only by measurable biological factors, but
also by the migration of cells to replace cells damaged by radiation, as well as the
patient's perception. However, authors of the article [14] notice that the according to
their research the major part of volume effect is contained in organ’s architecture and
way of functionality. 
The main difficulty is related to the fact that laboratory tests are carried out
mainly  with  small  animals  (rats  and  mice).  The  specific  amount  of  the  reaction
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volume of the organ exposed to radiation may be critical, but it is difficult to scale
over a wide range of body sizes. 
3.4 Equivalent uniform dose (EUD)
Equivalent  uniform dose  (EUD)  is  the absorbed dose if  it  homogeneously
distributed in the tumor:




where vi is volume, received dose Di;
α is  tissue-specific parameter that describes the volume effect: for tumors is
negative value, for organ at risk (OAR) is positive.
The cell survival-based EUD concept assumes that the dose distributions are
biologically equivalent if the number of killed cells are identical, when α is equal to 1
EUD is equal to mean dose.
The α is a large negative value for tumor as the tumor control depends on the
minimum dose received by the tumor. In case of normal tissues such as serial and
parallel  architectures,  the values of  α are large positive and small  positive values
depending on small and large volume effects respectively. 
Except EUD, EQD2 can be a value for comparison of different fractionation
modes,  where  EQD2 is  the  dose  delivered  in  2  Gy fractions  that  is  biologically





Typically α/β = 10 Gy for early-responding tissues and tumors and 3 Gy for
late-responding tissues (normal tissue).
It is important to note that value of EQD2 can be numerical sum of separate
parts of irradiation mode, implemented with different single dose.
3.5 The model of Niemierko for the tumor control probability (TCP) and 
the normal tissue complication probability (NTCP)
Mathematical  expression  of  tumor  control  probability  (TCP)  determine
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probability of  absent  viable colony forming cells in tumor after  irradiation,  using
binomial ( in limit Poison) probability distribution: 
TCP (N 0 , D )=∏
i=1
N0
(1 − SF ( D ) )=(1− SF ( D ) )
N 0 ≈ exp (− N 0 SF ( D ))=exp (− V 0⋅ρ0 SF ( D ) ) , (6)
where N0 is number of colony forming cells in tumor,
V0 is volume of tumor, cm3;
ρ0 is density of malignant cells, cm-3;
SF(D) is a function of surviving malignant cells irradiating in dose D. 
The transition to the Poisson distribution does not allow the fulfillment of the
limit  relation:  when  D  = 0,  SF(D)  = 1,  than TCP is  not  equal  to  zero.  But  it  is
neglected on practice. 










where TD50 is  control of 50% of the tumor with a dose of a uniformly irradiated
tumor,Gy;
γ50 is coefficient of LQ-model, specific for tumor and determine slop of curve
in LQ-model;
EUD is a equivalent uniform dose, calculated by formula (4).
The  model  of  Niemierko  for  the  normal  tissue  complication  probability









where TCD50 is tolerant dose for 50% of the complication rate for a certain period of
time when the whole organ is irradiated uniformly, Gy;
γ50 is coefficient of LQ-model, specific for normal tissue and determine slop
of curve in LQ-model;
EUD is a equivalent uniform dose, calculated by formula (4).
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Figure 12 shows example of NTCP and TCP curves.
Figure 12 – Example of NTCP and TCP curves
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4 Practical part
4.1 Literature review 
In  literature  review  researches  which  match  to  follow  parameters  was
considered:
- publication years: 1989 – 2021; 
- type  of  treatment:  radiation  therapy  with  combination  of  chemotherapy,
immunotherapy; 
- localization:  head-and-neck  region,  mainly  pharynx,  oropharynx,
hypopharynx;
- stages  of  disease:  mainly  T3,4  (incl.  III,  IV)  stages,  according to  TNM
classification [17];
- type of radiation: photons;
- primary tumor;
- mainly without surgical interruption.
Table  A.1 summarizes  the  studies  reviewed,  all  dose  for  tumor  were
recalculated  according  to  equation  (5)  in  EQD2 with  α/β = 10 Gy.  Local  or









where d is number of adverse outcomes (deaths) at time i;
n is number of patients who are observed at time i.
Treatment  of  head-and-neck  tumors  with  chemoradiation  therapy  is
considered in studies [18 – 25]. Generally, according to results, 3-year locoregional
control  with  dose  bigger  than 69 Gy reaches  at  least  70 %.  High but  acceptable
toxicity  is  noted  for  conventional  and  accelerated [18,  19,  22,  24]  fractionation
modes. However Huang S. et al. [24] conclude that hypo fractionation mode can be
used as alternative treatment of chemoradiation therapy for some stage of cancer. 
In  work  of  Katsoulakis  E.  at  al  [26]  IMRT  and  3D  CRT  dose  delivery
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methods analyze. According to authors opinion, there was no increased local failure
with IMRT and IMRT has better 3-year locoregional control (for IMRT 85 %, for 3D
CRT 76 %).
Comparing  radiation  and  chemoradiation  treatment,  Calais  G.  et  al.  [27],
Denis F. et al. [28]  and Regine W. F. et al. [29] conclude that the most favorable
prognosis  will  be  in  the  case  of  concomitant  chemotherapy:  5-year  locoregional
control  is  56 % [27],  47 % [28]  for  chemoradiation  therapy  while  32 % [27],
24.7  [28] for radiotherapy.
Influence of immunotherapy is described in researches of Habl G. et al. [30]
and Ho C.  et  al.  [31].  Ho C.  et  al.  [31]  note  that  immunotherapy with radiation
therapy reach worse  3-year  tumor control  (43 %) comparing with chemoradiation
therapy(88 %),  high  side  effects  of  both  treatment  methods  belong  to  different
toxicity  profiles.  In  work  [30]  higher  side  effects  is  observed  for  patients  with
immunotherapy. 
Schüttrumpf L. et al. [32] write that it is important to stratify and optimize
procedure of radical chemotherapy and note that patients with human papillomavirus-
associated  oropharynx cancer  (HPVOPC) has  better  tumor control  parameters  for
conventional mode (3-year locoregional control 70 %). Low level of hemoglobin and
lymph nodes involvement,  according to  the authors,  leads  to  failure  in  long-term
perspective.
In  studies  of  Horiot  J.  C.  et  al.  [33]  and  Poulsen  M.  G.  et  al.  [34]  two
fractionation modes, accelerated and conventional, is compared. Better tumor control
is reached for accelerated mode, according to authors [33], however in research [34]
there was no significant difference between the modes. Both studies note about high
toxicity of normal tissue.
For plotting TCP function, in first way, value of TD50 was averaged for all the
indicated tumors [4], according to stages III, IV [17] (i. e. either T3 – 4, or T2 with
N1 – 3) with irradiation time of 49 days, recalculated by equation (5). Than TD50 is
equals  to  (70.6 ± 2.6) Gy.  Slope  of  curve,  γ50,  was  determined  through  TD50 and
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TD90 = (73.7 ± 2.6) Gy, which was calculated with the same way as TD50. Figure 13
shows obtained result: for  TD50 = 73.2 Gy,TD90 = 71.6 Gy  γ50 is negative value, for
TD50 = 70.6 Gy, TD90 = 71.6 Gy and TD50 = 73.2 Gy, TD90 = 73.7 Gy γ50 is very large,
77.8 and 80.7 respectively, that does not make sense.
Figure 13 – γ50 for different TD50 and TD90, points on plot: TCP(20 Gy) = 0 %, TCP(TD50) = 50 %,
TCP(TD90) = 90 %,TCP(100 Gy) = 100 %
From other hand, in study of Okunieff M. D. et al. [35] values of TD50 and γ50
study  are  different  from  study  [4]  mentioned  above.  Here  some  of  them  are
considered:
- Supraglottic, stage I, II, IIIa, TD50 = 63.43 Gy, γ50 = 2.66;
- Pharyngeal wall, stage T1–4, TD50 = 63.66 Gy, γ50 = 4.01;
- Pharyngeal wall, stage T3+T4, TD50 = 72.19 Gy, γ50 = 0.8;
- Supraglottic, stage IIIb, IV, TD50 = 83.35 Gy, γ50 = 0.97.
Figure  14,  15 show TCP curve for head-and-neck tumors, the points on the
curve correspond to the results (tumor control) of the studies indicated in Table A.1
according  to  their  serial  number.  TCP  curve  is  plotted  only  for  TD50 = 70.6 Gy
because deviation for this value was calculated. 
34
Figure 14 – TCP for 3 years, dashed lines represent error limits for mean, where
TD50 = (70.6 ± 2.6) Gy
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Figure 15 – TCP for 5 years, dashed lines represent error limits for mean, where
TD50 = (70.6 ± 2.6) Gy
According to obtained plots, it can be seen that generally calculated TD50 and
γ50 are in good agreement with the data from the literature review for conventional
mode, while the data obtained by [35] are applicable more or less only for 3-year
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locoregional control. For 3-year locoregional control, a high γ50 (7.1 and 12.8) would
probably be better combined with a TD50 of slightly less than 70.6 Gy. However, for
5-year  locoregional  control  the current  calculated parameters  fall  within the error
limits of the mean.
Points 1, 2, 5, 6, 13, some of 7 and 17 for the 3-year and 5-year locoregional
did  not  fall  within  the  error  limits,  possibly  due  to  the  use  of  hypo-  or
hyperfractionation. According to plot, it can be seen that this values located to the left
in  area  with  lower  total  dose,  but  bigger  part  of  this  points  are  not  inferior  to
locoregional control for conventional mode.
Figure 16 show TCP for 35 and 42 days of treatment (overall treatment time)
for all tumor sites [4].
Figure 16 – TCP for two treatment duration,dashed lines represent error limits for mean, 
where TD50 (35 days)= (61.6 ± 2.4) Gy
TD50 (42 days)= (65.5 ± 3.0) Gy
Head-and-neck tumors are fast-growth malignancies and thereby duration of
the course has a very large impact, including on the final total dose. With an increase
in the duration of the course, the dose of TD50 increases noteworthily (Figure 13, 16),
the proliferative ability of tumor cells significantly reduces the effect of radiation,
which should be compensated by an increase in the total dose, or reduction in the
duration of the course. 
Figure  17 shows  points  of  locoregional  control  for  hypo-  or
hyperfractionation modes according to Table A.1.
37
Figure 17 – TCP for 3-year (points 2, 6, 7, 9, 13,) and 5-year (points 1, 5, 16, 17) locoregional
control for two treatment duration,dashed lines represent error limits for mean, where TD50 (35
days)= (61.6 ± 2.4) Gy, TD50 (42 days)= (65.5 ± 3.0) Gy
Points  12 did  not  considered because,  despite  on hypofractionation  mode,
total duration of treatment is almost the same as for conventional mode due to total
dose escalation.  According to Figure  17,  control  for  hypo- and hyperfractionation
modes fits well to data for 35 and 42 days of treatment duration. 
In studies corresponding to points 12, 14 for 3-year locoregional control and
10, 11 for 5-year locoregional, oropharynx is predominant as a site of tumor, but in
most  of  the  studies  shown  on  the  plot,  the  oropharynx  is  also  one  of  the  most
common sites.
According to literature review the following statement can be concluded: 
- conventional mode (70 Gy, 35 fractions) leads to wide range of results and
all of them do not fall lower 70% for 3 years control (points 4, 6, 7, 8, 9, 13, 14, 15)
but for 5 years locoregional control is located around 50% (points 3, 10, 11, 16, 17);
- for  5  years  local  control  for  non-conventional(accelerated,  hypo-  or
hyperfractionation) mode bigger than for conventional but for 3 years this difference
do not significant ( points 1, 5, 16, 17); 
- decreasing of dose lower than 66 Gy do not leads to sufficient tumor control
already after three years of observation (points 2, 3);
- obtained in study of Maciejewski B. et. al. [4] values of TD50 and calculated
values of  γ50 correlate well with experimental data almost of all mentioned studies,
therefore, they will be used for further TCP calculation of real patients.
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4.2 Patient treatment analysis
The data in this section was obtained from two different cities and different
therapeutic devices:
- Tomsk, Tomsk Regional Oncology Center, Elekta Synergy;
- Tyumen,  Tyumen  Regional  Oncological  Dispensary,  Varian  TrueBeam
STx, Varian Clinac, Elekta Synergy.
Table 1 contains brief description of studying patients.
Table 1 – Brief Description of patients




IMRT, 70 Gy, 2Gy – tumor, 50 Gy, 2 Gy









IMRT, 70 Gy, 2 Gy – tumor, 60 Gy, 2 Gy





VMAT, 70 Gy, 2 Gy – tumor, 50 Gy,






VMAT-SIB, 70 Gy, 2.5 Gy – tumor**,





IMRT-SIB, 70 Gy, 2.5 Gy – tumor**,





3D CRT, 70 Gy, 2 Gy– tumor, 54 Gy,
2 Gy– lymph nodes 
Tomsk
Patient 8*
T3N0M0 III, base of
tongue cancer
VMAT-SIB,70 Gy, 2.5 Gy – tumor**,
50 Gy, 2 Gy– lymph nodes 
Tomsk
Patient 9
T2N1M0 III, cancer of the
lateral surface of the
tongue
VMAT, 70 Gy, 2.12 Gy – tumor**,
affected right lymph node, 60 Gy, 1.8 Gy







VMAT, 70 Gy, 2 Gy– tumor, 50 Gy, 2 Gy






VMAT, 70 Gy, 2 Gy – tumor, 50 Gy,






VMAT, 70 Gy, 2 Gy – tumor, 50 Gy,






VMAT, 70 Gy, 2 Gy – tumor, 50 Gy,




Continuation of Table 1




IMRT-SIB, 70 Gy, 2.5 Gy – tumor**,

















** dose for tumor according to equation (5) with α/β = 10 Gy: 
EQD2 (70 Gy, 2.5 Gy) = 72.9 Gy, EQD2 (70 Gy, 2.12 Gy) = 70.7 Gy
In the process of work, a program has been developed for conversion of the
integral DVH into a differential one for subsequent calculations of EUD, TCP and
NTCP.  Appendix  B consists  of  two DVH examples  from different  software  (for
Elekta – Monaco, for Varian – Eclipse).
Figure  18 and  19 shows two examples of  differential  and integral  DVH for
tumor and OARs of patients. 
Figure 18 – DVH for tumor and OARs for patient 3, where PTV_Tumor is planning target volume
for tumor: A – integral DVH, B – differential DVH
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Figure 19 – DVH for tumor and OARs for patient 12, where PTV_Tumor is planning target volume
for tumor: A – integral DVH, B – differential DVH
Calculated by equations 4, 7, 8 EUD, TCP, NTCP, respectively, are listed in
Table 2 (TCP) and Table C.2 (NTCP), Table C.1 consists of parameters for EUD and
NTCP calculations. TCP was calculated based on TD50 value  according to tumor site
and  stage  of  disease  [4,  35]  with  using  equation  (5)  if  necessary,  for  EUD
α = - 8 [36]. 
Table 2 – Obtained EUD ans TCP for all patients




TD50 = 66.3 Gy
γ50 = 11.3
5.4 % Patient 9 70.34
TD50 = 69.8 Gy
γ50 = 9.4
57.1 %
Patient 2 72.08 97.8 % Patient 10 66.31





62.87 TD50 = 71.3 Gy
γ50 = 12.1
0.02 % Patient 11 64.56 TD50 = 70.6** G
y γ50 = 12.8**
1.0 %
Patient 4 71.36 51.1 % Patient 12 71.28 71.3 %
Patient 5 71.38
TD50 = 65.8 Gy
γ50 = 12.3
98.2 % Patient 13 69.73




Continuation of Table 2
№ EUD, Gy  TD50, γ50 TCP № EUD, Gy  TD50, γ50 TCP
Patient 6 71.53
TD50 = 66.8 Gy
γ50 = 12.1
96.5 % Patient 14 71.70






TD50 = 69.8 Gy
γ50 = 9.4
68.0 % Patient 15 67.47




TD50 = 65.6 Gy
γ50 = 9.5
97.8 % Patient 16 67.31 70.9 %
*gamma  analysis  (%  Passed)  values  obtained  when  checking  the  plan  with  Sun  Nuclear
ArcCHECK are shown in brackets
** for laryngeal cancer with IV stage and hypopharynx cancer with III stage the obtaining values
of TD50 and  γ50 calculated early was taken
Taking  into  account  fractionation  mode  and  treatment  duration,  it  can  be
concluded that locoregional control for patient in Table 2 will, in general, correspond
to the locoregional control for the classic regime indicated in the literature review:
- 3-year locoregional control is about 65 – 75 %;
- 5-year locoregional control is about 40 – 50 %.
For patients 1, 3 and 11 who has 70 Gy as total dose this prediction is not an
exception because described irradiation methods in literature review with total dose
70 Gy do not mean that EUD also will be equal to 70 Gy. 
It is worth noticing that following differences in control calculation methods
has important and affect on final result:
- The difference in the calculation method: the results obtained in Chapter 4.1
are calculated using equation 9, while those obtained in the study are calculated using
equations 4, 7, 8.
- Statistical  data  processing:  the  studies  considered  in  Chapter  4.1  are
obtained for a group of people and, therefore, are averaged. 
- The parameters used for TCP calculation may not be true values.
Also almost all mentioned studies in literature review has total dose around or
equal 70 Gy but EUD value is unknown. For example, prescribed dose for patient 2 is
70 Gy but EUD is 72 Gy. This value indicates uniform coverage that leads to better
treatment results (including tumor control) than prescribed dose. The opposite effect
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can be observed for patient 1. A similar prescribed dose results in an EUD of less
than the TD50 due to insufficient or uneven coverage, which results in less than 10%
tumor control. For patient 16, the prescribed dose is 60 Gy, however the EUD is
67 Gy. This value represents the threshold for 70% dose control. Consequently, the
control  value  depends  not  only  on  the  delivered  dose,  but  also  on  the  dose
distribution, coverage, inside volume of interest.
The next point is that not for all tumor sites 70 Gy is enough to reach 70 % of
locoregional control, according to TD50, γ50 values, which used. Particularly, advanced
stage of oropharyngeal cancer require at least 72.6 Gy of EUD for 70 % of control.
But this problem can be solve if decrease treatment time. 
It can be seemed that difference in TD50 is 9 Gy between averaged values for
49 and 35 days  (Figure  13,  16).  In theory,  for  patient  4 with the same dose but
decreased treatment duration, local control can be 100 % for 35 days and 96 % for 42
days. 
Also patients 5, 6 and 8 irradiated with SIB where fraction dose for tumor is
2.5 Gy. Treatment duration for this patients was equalized to 42 days (real duration a
little bit less but the exact  duration is unknown), for patient 10 with 2.12 Gy per
fraction for tumor treatment duration was taken as 49 day because real duration is
between 42 days and 49 days and also is unknown. It can be noticed that control for
patient 6 is much more than for patient 4 who has the same stage and site of disease.
Moreover, EUD of patient 4 is not enough for 70 % of TCP while TCP of patient 6 is
very large with almost the same dose. Similar conclusion can be made for patient 7
and 8, but, in this case, great importance is method of dose delivery: dose distribution
of VMAT is better than 3D CRT. 
According  to  literature  review,  3-year  locoregional  control  for  hypo-  or
hyperfraction therapy is about the same but hypofractionation for 5-year gives better
results than conventional mode.
For  normal  tissues,  according  to  the  results  of  Table  С.2,  the  doctor's
examinations and the studied sources in Chapter 4.1 (Table 1, Figures 14, 15), acute
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radiation  reactions  develop approximately the same,  and late  ones,  as  a  rule,  are
absent provided that the tolerance of the organ is observed:
- at 3 – 8 weeks epitheliitis of a different sites appears;
- xerostomia, esophagitis, candidiasis, mucositis, dermatitis, stomatitis (if the
mandible falls into the irradiation area of the tumor or lymph nodes) with 3 – 4 grade
of severity.
Early radiation reactions, excluding epithelitis, have a different duration, in
particular, on average, xerostomia lasts at least a year.
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5 Financial management, resource efficiency and resource saving
5.1 Project initiation
Initiation processes define initial  goals and content and fix initial financial
resources. The internal and external stakeholders of the project are determined, which
will interact and influence the overall result of the scientific project.
5.1.1 Project goals and results
Information about the hierarchy of project  goals and criteria for  achieving
goals is given in the Table 3.
Table 3 – Project goals and results
Project goals
Estimation of expected radiation treatment effectiveness of head-and-
neck cancer, predicting treatment results based on the research 
performed, statistical evaluation of data.
Expected results of the 
project
The classical regime of treatment does not lead to the satisfactory 
control of tumor, i.e. to the desired treatment outcomes.
Acceptance criteria of the 
project result
Proposal and justification for choosing an alternative solution
Requirements to the 
project results
Project completion on time
Alternative treatment offer
5.1.2 Organization structure of the project
The organizational structure of the project is presented in the Table 4.
Table 4 – Project Working Group
№ Name Position Functions
Hours
spent
1 Klinovitskaia M.I. Student Work on project implementation 416
2 Sukhikh L.G. Superviser
Coordination of work activities and
assistance in project implementation
120
Total: 536
As a result of the initialization of the project, the goals and expected results
were formulated, the stakeholders of the project and the financial framework were
identified, which is very important for the successful completion of the project and its
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implementation.
5.1.3 Deadlines for the project stages
Deadlines for the project stages are listed in Table   5. In addition, Table  6
visualized project schedule in form of bar chart also called Gantt chart.
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Table 5 – Project timeline
Job title Duration, working days Start date Date of completion Participants
Drawing up the technical
assignment
5 15.03.2021 19.03.2021 Supervisor
Calendar planning 6 20.03.2021 29.03.2021 Supervisor, Student 
Literature review 22 30.03.2021 28.04.2021 Student 
Selecting a radiological
model
3 29.04.2021 3.05.2021 Student
Mathematical analysis of
data
2 3.05.2021 4.05.2021 Student
Development of a program
for working with data
1 4.05.2021 4.05.2021 Student 
Calculation equivalent
uniform dose, tumor control
probability
1 5.05.2021 5.05.2021 Student
Predicting treatment
outcomes based on literature
review
3 6.05.2021 10.05.2021 Student 4
Summarizing 4 10.05.2021 13.05.2021 Supervisor, Student
Drawing up a final report 10 14.05.2021 27.04.2021 Student 
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Duration of the project
March April May
3 4 1 2 3 4 1 2 3 4





3 Literature review Student 22
4 Selecting a radiological model Student 3
5 Mathematical analysis of data Student 2
6















10 Drawing up a final report Student 10
* Tc – calendar days
Supervisor Student
Total duration: Klinovitskaia M.I. (Student) – 52 days, Sukhikh L.G. (Supervisor) – 15 days
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5.1.4 Project budgeting
The  project  budget  must  display  reliable  values  for  all  types  of  costs
associated with its implementation. The costs of this project include:
━ Costs of purchasing equipment;
━ Costs for materials and other products;
━ Expenses for the main and additional salaries of the theme performers;
━ Costs for special equipment;
━ Costs of social security contributions;
━ Overhead costs.
5.1.4.1 Costs of purchasing equipment
Table 7 shows needful basic equipment and accessories, and also its cost for
scientific work.
Table 7 – Cost of equipment and accessories for project
Name of equipment Quantity, units Price per unit, rub
Total cost for position,
rub
Monitor 1 10000 10000
Hard Disk Drive 
(HDD)
1 5000 5000
Computer mouse 1 300 300








Motherboard 1 7000 7000
Total: 47000
All equipment (but not accessory) indicated in the table is in stock and does
not require purchase, therefore, the price of equipment is determined by amortization
costs. depreciation charges.
Depreciation is  the gradual  transfer  of  costs  incurred to purchase  or  build
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property,  plant  and equipment  to  the cost  of  the  finished  product.  With its  help,
money  spent  on  the  construction  or  purchase  of  property  is  compensated.
Depreciation deductions are paid during the entire period of property exploitation.
Deprecation were calculated in linear way, annual (ND) and academic year (D)












Where  t – operating life, years;
S – price of one unit, rub;
T – number of working days.
Table 8 shows obtained results. 
Table 8 – Depreciation of equipment for project




Hard Disk Drive 
(HDD)
7 14.30 50
Computer mouse 1 100 43








Motherboard 15 6.70 66
Total: 527
5.1.4.2 Costs of additional materials
Table 9 shows needful other materials for scientific work. These costs include
office supplies,  printing costs  and various equipment required for  research except
specialized equipment.
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Table 9 – Cost of additional materials for project
Name of equipment Quantity, units Price per unit, rub
Total cost for position,
rub
Pen 2 10 20
Paper 2 packs (200 units) 60 120
Folder 1 5 5
Stapler 1 150 150
Staples 1 pack (48 units) 40 40
Hole puncher 1 250 250
Total: 585
5.1.4.3 Salary
The amount of expenses for wages of employees is determined based on the
labor intensity of the work performed and the current system of salaries and tariff
rates.
The calculation of the basic salary of the head of a scientific project is based
on the sectoral wage system. The branch system of remuneration at TPU assumes the
following composition of wages:
- Salary – determined by the enterprise. In TPU, salaries are distributed in
accordance  with  the  positions  held,  for  example,  assistant,  art.  lecturer,  associate
professor, professor.
- Incentive payments – set by the head of departments for effective work,
performance of additional duties, etc.
- Other payments, district coefficient.
Since  incentive  bonuses,  other  payments  and  incentives  depend  on  the
activities  of  the  manager  in  particular,  we  will  take  the  coefficient  of  incentive
bonuses  (kb)  equal  to  30%, and the coefficient  of  incentives  for  the  manager  for
conscientious work (kpr) activity is 25%, regional coefficient (kr) – 1.3.





where   SM – monthly salary, rub;
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Fd – average number of working days in a month, days.
Monthly salary SM can be determined according next equation:
S M=S r⋅(1+k pr+k b)⋅ k r[rub ] . (13)
where   Sr – average daily salary, rub;
Additional salary:
S add=k extra⋅S M [rub] . (14)
where   kextra – additional salary coefficient (10-15%). For calculation values 10% is 
  used.
Average number of working days in a month Fd was determined as:
F d=247/12=20.58 , (15)
where 247 – number of working days in year. 
The basic salary Sb is determined by next equation:
S b=S d⋅T [rub ] , (16)
where  Sd – average daily salary, rub;
T – duration of work, days.




[rub ] . (17)
Additional salary for the entire project period:
S ADD=S D⋅T [rub] . (18)
Full salary for the period of the project:
S=S b+S ADD[rub ] . (19)
Table  10 shows obtained values for salary,  Sr    is average value for Tomsk.
Student was equalized to engineer-researcher.
Table 10 – Salaries of participants in the project




Sukhikh L.G. 45000 90675 9067.5 4406 15 66089.7 440.6 6609 72698
Klinovitskaia
M.I.
20000 40300 4030 1958.2 52 101827 195.8 10182.7 112009
Total: 184707
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5.1.4.4 Contributions to social funds 
Here  I  will  consider  the  obligatory  contributions  according  to  the  norms
established by the legislation of the Russian Federation to the state social insurance
bodies (FSS), the pension fund (PF) and medical insurance (FFOMS) from the costs
of wages of employees. The amount of contributions to extra-budgetary funds Sexb is
determined by the formula:
S exb=kexb (Sb+S ADD)[rub ] , (20)
where   kexb – contribution rate to extrabudgetary funds.
In accordance with Federal Law No. 212-FZ of 24.07.2009, the amount of
insurance premiums is set at 30 %. On the basis of paragraph 6 of Part 1 of Article 58
of Law No. 212-FZ for institutions engaged in educational and scientific activities in
2019. there is a reduced rate of 28 %.
Table 11 shows contributions to social funds.
Table 11 – Contributions to social funds




Klinovitskaia M.I. 112009.7 31362
Total: 51718
5.1.4.4 Overhead costs
Average operating time for Researcher 1 – 320 hours , rate – 2,97 rub/kWh,
for Researcher 2 – 320 hours , rate – 2,56 rub/kWh, for Student (laptop) – 416 hours ,
rate – 2,56 rub/kWh.
Electricity costs are calculated using the formula:
С=R el⋅Р⋅t ,[rub] , (21)
where   Rel– industrial electricity tariff rate, rub/kWh;
Р – equipment power, kW;
t – time of equipment use, h.
Equipment power was taken as 0.065 kW.
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Table 12 shows overhead cost.
Table 12 – Overhead costs









Printing 2 rub/pages 150 300
Total: 1542
n – amount of service using according to units in rate (for electricity – hours, for internet – month)
5.1.4.5 Formation of the budget of the costs of a research project
The total budget of research costs shown in the Table 13.
Table 13 – The total budget of research
Name Cost, rub Cost, %
Costs of purchasing equipment 527 0.02 %
Costs of additional materials 585 0.02 %
Supervisor salary costs 72698 30.4 %
 Student (Researcher) salary costs 112009 47.5 %
Contributions to social funds 51718 22 %
Overheads 1542 0.06 %
Research budget 239079 100
5.2 Economic model development
5.1.2.1 Potential consumers of the research results
In  order  to  find  out  in  which  direction  to  conduct  research,  a  consumer
analysis was made. The Table 14 shows a map of the segmentation of the market for
patients with malignant neoplasms in the head-and-neck region, depending on age. 
Table 14 – Segmentation of patients with cancers in head-and-neck region [1]
Age of patients, years
0 – 19 20 – 44 45 – 64 65 and older
Localization Tonque 2 303 1888 1278
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Continuation of Table 14
Age of patients, years
0 – 19 20 – 44 45 – 64 65 and older
Oropharynx 1 197 1775 898
Laryngopharynx 1 143 1437 886
According to data it can be concluded that the biggest number of cases occur
in middle age. People in this age group, in contrast to the elderly population, do not
have enough palliative treatment, they need full therapy, which will provide them
with the opportunity to live to old age in a satisfactory condition.
It is difficult to draw conclusions about old age, as the share of the population
that has overcome the threshold of 75-80 years is small. 
5.1.2.2 Analysis of alternative technical solutions
Analysis of competitive technical  solutions in terms of resource efficiency
and resource saving allows to evaluate  the comparative effectiveness  of  scientific
development. For this purposes evaluation card is used. 
As an alternative solution, 3 methods of increasing tumor control by changing
the total dose and fractionation were considered:
- Conventional fractionation mode with chemotherapy; 
- Hypo- or hyperfractionated mode with chemotherapy;
- radiation therapy alone with conventional fractionation.
The  position  of  the  development  and  competitors  is  assessed  for  each
indicator by an expert method on a five-point scale: 1 - the weakest position, 5 - the
strongest. The weights of the indicators, determined by expert judgment, should add
up to one.
The analysis of competitive technical solutions is determined by the equation:
C=∑ Pi⋅W i , (22)
where   С – the competitiveness of research or a competitor;
Wi– criterion weight;
Pi – point of i-th criteria.
55
The  Table  15 shows  comparison  of  three  solutions:  index  f means
conventional mode with chemotherapy,  i1 – hypo- or hyperfractionated mode with
chemotherapy, i2 – radiation therapy with conventional fractionation.





Pf Pi1 Pi2 Cf Ci1 Ci2
1 2 3 4 5 6 7 8
Technical criteria for evaluating resource efficiency
1.Critical organ sparing 0.2 4 4 4 0.8 0.8 0.8
2.Tumor control 0.2 4 5 3 0.8 1 0.6
3.Cell proliferation 0.08 4 5 3 0.32 0.4 0.24
4.Acute toxicity 0.08 4 3 5 0.32 0.24 0.4
5.Late toxicity 0.04 4 4 4 0.16 0.16 0.16
6.Radiosensitivity 0.08 4 4 3 0.32 0.32 0.24
Economic criteria for performance evaluation
1.Price 0.13 4 4 5 0.52 0.52 0.65
2.Time expenditures 0.05 3 4 3 0.15 0.2 0.15
3.Market penetration 0.07 5 4 3 0.35 0.28 0.21
4.Method competitiveness 0.07 4 5 3 0.28 0.35 0.21
Total 1 40 41 32 4.02 4.27 3.66
According to comparison the most technically and economically profitable is
implementation chemotherapy with hypo-  or  hyperfractionation mode of  radiation
therapy. Radiation therapy alone now is not used method of treatment for head-and-
neck tumors, due to low effectivity. Conventional fractionation  with chemotherapy is
the most common way to treat, but now this method should be revised. 
5.1.2.3 SWOT-analysis
Complex analysis  solution with the greatest  competitiveness  is  carried out
with the method of the SWOT analysis: Strengths, Weaknesses, Opportunities and
Threats. 
Strengths  are  factors  that  characterize  the  competitive  side  of  a  research
project.  Strengths  indicate  that  a  project  has  a  distinctive  advantage  or  special
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resources that are special in terms of competition. In other words, strengths are the
resources or capabilities that project management has and that can be effectively used
to achieve the goals set.
Research strengths include:
- Analysis of therapies for head-and-neck radiotherapy over the past 30 years.
- Application of the most modern method of treatment – VMAT.
- High-tech equipment and accessories.
Weaknesses  are  a  flaw,  omission  or  limitation  of  a  research  project  that
hinders the achievement of its objectives. This is something that does not work well
within  a  project  or  where  it  lacks  the  capacity  or  resources  compared  to  its
competitors.
Weaknesses of research work:
- A large number of patients are needed to obtain meaningful values.
- Patients  are  randomized,  it  is  impossible  to  check the  influence  of  age,
gender and other factors on treatment.
- Failure to account for the effect of chemotherapy on treatment.
Opportunities include any preferable present or future situation that arises in
the project's environment, such as a trend, change, or perceived need, that sustains
demand for  project  outcomes  and  allows  the  project  management  to  improve  its
competitive position.
Opportunities include:
- Improving the quality of treatment.
- Review and analysis of a large number of patients.
A threat is any undesirable situation, trend, or change in the environmental
conditions  of  a  project  that  is  destructive  or  threatening  to  its  current  or  future
competitiveness. A threat can be a barrier, restriction, or anything else that can cause
problems, destruction, harm or damage to the project.
Threats include:
- Equipment breakdown during treatment.
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- Refusal of the patient to continue treatment.
- Failure to comply with positioning requirements.
Table 16 presents the final SWOT-analysis matrix. 
Table 16 – SWOT-analysis
Strengths:
S1. Analysis of therapies for 
head-and-neck radiotherapy 
over the past 30 years.
S2. Application of the most 
modern method of treatment – 
VMAT.
S3. High-tech equipment and 
accessories.
Weaknesses:
W1. A large number of patients 
are needed to obtain meaningful
values.
W2. Patients are randomized, it 
is impossible to check the 
influence of age, gender and 
other factors on treatment.
W3. Failure to account for the 
effect of chemotherapy on 
treatment.
Oportunities:
O1. Improving the quality of 
treatment.
O2. Review and analysis of a 
large number of patients.
S1O1. The work is aimed at 
analyzing existing and accepted
methods of treatment, as well as
finding new and alternative 
ones that will improve the 
quality of treatment.
S2O1. VMAT, in comparison 
with other methods, allows to 
increase control on the tumor 
and reduce the dose to 
neighboring organs.
W1O1. The project involves 
two localities, which allows  to 
increase the sample if it need to 
create a larger study.
W1O2. With a large sample, it 
is possible to analyze the 
influence of some factors on the
course and outcome of 
treatment. 
Threats:
T1. Equipment breakdown 
during treatment.
T2. Refusal of the patient to 
continue treatment.
T3. Failure to comply with 
positioning requirements.
T2S2. Patient refusal from 
treatment is associated with 
early radiation effects, which 
can be minimized by using 
more accurate dose delivery 
using VMAT.
T3S3. Use of modern 
equipment and accessories 
minimizes positioning errors.
W1T2. Refusal of a patient to 
continue treatment complicate 
preparation of large samples.
W1T3. In the presence of a 
large number of patients, the 
likelihood of a positioning error
due to the human factor 
increases, including a shortage 
of immobilization equipment.
5.1.2.4  Methods  of  commercialization  of  the  results  of  scientific  and
technical research
Transfer of know-how was chosen as a suitable method of commercialization.
In general, the aim of the current work is to analyze the effectiveness of treatment
with  the  classical  method  and  assess  the  need  to  find  an  alternative  solution.
Proceeding  from  this,  the  obtained  results  of  the  work  can  be  used  by  any
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organizations  involved  in  the  field  of  radiotherapy  for  further  own  research  or
application.
Basically,  oncological  dispensaries  (“representatives”  of  radiation  therapy)
are municipal institutions, therefore financing of such institutions providing by city,
however, it is possible that outside interested investors will be attracted. 
Improving the quality of treatment, in financial terms, entails an increase in
the number of potential customers, i.e. patients who will go to a specific hospital,
which will increase the flow of profits either to the city budget or to the budget of a
private entrepreneur.
There is an ambiguous situation in the identification of potential competitors.
In  terms  of  service  delivery,  competitors  are  any  center  that  provides  radiation
therapy  on  more  modern  equipment.  From  a  research  point  of  view,  as  such,
competitors are also focused on finding the optimal treatment, and as soon as the
necessary amount of data (reliable statistics) is available, the new treatment method
will be recognized and legalized. But, according to the method of commercialization
that was indicated, the technology will be located in the public domain, which will
allow it to be used regardless of the location of the study. Also, it is worth pointing
out that  when conducting such studies,  in order to obtain reliable results,  a  large
amount of data is needed, which, as a rule, are collected in more than one place (not
in one hospital or city), which leads to the "implementation" of the study in several
places at the same time, which reduces the number of potential competitors in such
studies.
Foreign  research  can  be  an  exception,  because  the  introduction  of  a  new
solution method abroad does not mean legalizing it in any other country. In this case,
there  may  be  an  outflow  of  potential  clients  (patients)  to  countries  with  better
treatment.
Also it should be emphasized that the implementation of the classical solution
method and the alternative is carried out on the same equipment and does not require
additional financial costs.
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5.3  Evaluation  of  the  comparative  efficiency  of  the  scientific  research
project
Determination  of  efficiency  is  based  on  the  calculation  of  the  integral
indicator of the effectiveness of scientific research. Its finding is associated with the
determination of two weighted averages: financial efficiency and resource efficiency.
Integral  financial  indicator I f
p  of  a  scientific research is  obtained in the
course  of  assessing  the  budget  of  the  costs  of  three  (or  more)  variants  of  the
implementation of a scientific research. For this, the largest integral indicator of the
implementation  of  a  technical  problem  is  taken  as  the  calculation  base  (as  the
denominator), with which the financial values for all execution options are correlated.
Integral  financial  indicator  I f








where Fрi – price for i-th variant of execution; 
Fmax – maximum cost of execution of a research project (including analogs).
The resulting value of the integral financial indicator of development reflects
the corresponding numerical increase in the budget of development costs in times (a
value  greater  than one),  or  the  corresponding  numerical  reduction  in  the  cost  of
development in times (a value less than one, but higher than zero).
The integral indicator of the resource efficiency I m
p , I m
a  of the variants of the
















Where    ai – the weight coefficient of the i-th parameter;
b i
a , b i
p – the score of the i-th parameter for the analog and development, set
by an expert  method on the selected rating scale,  index  a means alternative,  p –
project;
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n – the number of comparison parameters.
The implementation of all three alternatives is economically equal, since the
analysis is carried out without equipment. However, even with the application of the
research  results,  any  therapeutic  radiation  therapy  equipment  will  be  able  to
implement the indicated fractionation modes.
Table 17 shows comparison for way which is used and two alternative. 











1. Critical organ sparing 0.2 4 4 4
2. Tumor control 0.3 4 5 3
3.Novelty 0.1 4 5 3
4.Scope of application 0.2 4 5 3
5. Price 0.2 4 4 5
Total: 1 20 23 18
*ChemoCRT – chemotherapy with conventional mode;
ChemoHypRt – chemotherapy with hypo- or hyperfractionation mode;
RT – radiation therapy alone with conventional fractionation.
An integral efficiency indicator of the scientific research project  I fin
p  and of
the analog I fin
a  are determined according to the formula of the integral basis of the
















Comparison of the integral indicator of the efficiency of the current project and







All calculated indicators are listed in Table 18.
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Table 18 – Comparative project efficiency
№ Indicator Project Alternative 1 Alternative 2
Final cost, rub 239079 239079 239079
1 Integral financial indicator I f
p 1 1 1
2
Integral resource efficiency indicator
I m
p , I m
a 4 4.6 3.6
3 Integral efficiency indicator I fin
a , I fin
p 4 4.6 3.6
4










Comparison  of  the  integral  indicator allows  to  understand  and  choose  a
cheaper option for solving the technical problem in terms of financial and resource
efficiency.  As a result,  it  can be concluded that  alternative 1,  chemotherapy with
hypo- or hyperfractionation mode, is best option along presented: all realization is
equal from economical view but from technical view alternative 1 is better. 
5.4 Conclusions
In this chapter, an analysis of the competitive technical solutions of scientific
research is carried out, in which it was found that the methodology chosen in the
study is the most preferable due to its availability and ease of use. The conducted
SWOT-analysis showed that the advantages of the developed methodology prevail
over its disadvantages, and the identified threats are removable.
For better planning of the work and the implementation of the work of the
performers, a Gantt chart was built, which clearly illustrates how much time it takes
to carry out a scientific research. The total number of calendar days during which the
student worked was 52, supervisor – 15.
Also, the estimate of the scientific research was determined, the main items of
expenditure  were  identified.  The  budget  for  this  research  work  amounted  to
239079 rubles.
Evaluation  of  the  effectiveness  of  research  work  was  carried  out  by
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determining  the  integral  efficiency  indicator  of  the  research.  Its  value  is 4.00
compared to 4.6 and 3.6 for alternatives. It means that scientific development is in




Research topic is estimation of expected radiation treatment effectiveness of
head-and-neck cancer  based on the equivalent  uniform dose  concept.  Application
area of research is radiation therapy, i.e. data can be used by a radiologist-oncologist
and a medical physicist for patients receiving radiation therapy. Radiation therapy is
carried out in special centers, which have rooms that provide for compliance with
radiation safety standards.
The work is aimed at revising the already used treatment method to assess the
need to introduce an alternative quality-enhancing one.
6.2 Legal and organizational items in providing safety
Nowadays one of the main ways to radical improvement of all prophylactic
work  referred  to  reduce  Total  Incidents  Rate  and  occupational  morbidity  is  the
widespread  implementation  of  an  integrated  Occupational  Safety  and  Health
management system. That means combining isolated activities into a single system of
targeted actions at all levels and stages of the production process.
Occupational safety is a system of legislative, socio-economic, organizational,
technological,  hygienic  and  therapeutic  and  prophylactic  measures  and  tools  that
ensure the safety, preservation of health and human performance in the work process.
According to the Labor Code of the Russian Federation, every employee has
the right[42]:
- to have a workplace that meets Occupational safety requirements;
- to have a compulsory social insurance against accidents at manufacturing
and occupational diseases;
- to  receive  reliable  information  from the  employer,  relevant  government
bodies  and  public  organizations  on  conditions  and  Occupational  safety  at  the
workplace, about the existing risk of damage to health, as well as measures to protect
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against harmful and (or) hazardous factors;
- to refuse carrying out work in case of danger to his life and health due to
violation of Occupational safety requirements;
- be  provided  with  personal  and  collective  protective  equipment  in
compliance with Occupational safety requirements at the expense of the employer;
- for  training in  safe  work methods and techniques  at  the  expense  of  the
employer;
- for personal participation or participation through their representatives in
consideration of issues related to ensuring safe working conditions in his workplace,
and in the investigation of the accident with him at work or occupational disease;
- for  extraordinary  medical  examination  in  accordance  with  medical
recommendations with preservation of his place of work (position) and secondary
earnings during the passage of the specified medical examination;
- for warranties and compensation established in accordance with this Code,
collective agreement, agreement, local regulatory an act, an employment contract, if
he is engaged in work with harmful and (or) hazardous working conditions.
The labor code of the Russian Federation states that normal working hours
may not exceed 40 hours per week, The employer must keep track of the time worked
by each employee.
Rules  for  labor  protection  and safety  measures  are  introduced in  order  to
prevent accidents, ensure safe working conditions for workers and are mandatory for
workers, managers, engineers and technicians.
6.3 Basic ergonomic requirements for the correct location and 
arrangement of researcher’s workplace 
The workplace when working with a personal computer (PC) should be at
least 6 square meters. The legroom should correspond to the following parameters:
the legroom height is at least 600 mm, the seat distance to the lower edge of the
working surface is at least 150 mm, and the seat height is 420 mm. It is worth noting
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that the height of the table should depend on the growth of the operator.
The  following  requirements  are  also  provided  for  the  organization  of  the
workplace  of  the  PC  user:  the  design  of  the  working  chair  should  ensure  the
maintenance of a rational working posture while working on the PC and allow the
posture to be changed in order to reduce the static tension of the neck and shoulder
muscles and back to prevent the development of fatigue.
The type of working chair should be selected taking into account the growth
of the user, the nature and duration of work with the PC. The working chair should be
lifting and swivel, adjustable in height and angle of inclination of the seat and back,
as  well  as  the  distance  of  the  back  from  the  front  edge  of  the  seat,  while  the
adjustment of each parameter should be independent, easy to carry out and have a
secure fit.
6.4 Occupational safety 
6.4.1 Analysis of harmful and dangerous factors that can create object of
investigation 
The object of investigation is radiation therapy. Object of investigation itself
can  be  source  of  harmful  and  (or)dangerous  factor  such  as  increased  levels  of
ionizing radiation and excessive noise.
6.4.2  Analysis  of  harmful  and  dangerous  factors  that  can  arise  at
workplace during investigation
The working conditions in the workplace are characterized by the presence of
dangerous and harmful factors:
- a dangerous  factor  or  industrial  hazard  is  a  factor  whose  impact  under
certain conditions leads to trauma or other sudden, severe deterioration of health of
the worker.
- a harmful factor or industrial health hazard is a factor, the effect of which
on a worker under certain conditions leads to a disease or a decrease in working
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capacity.
Based on the nature of the impact of these factors on the body, there are 4
categories:
- physical  factors (increased levels of noise and vibration, electromagnetic
and ionizing radiation, insufficient illumination, etc.);
- chemical  factors  (toxic,  irritant,  mutagenic  effects  of  substances  and
compounds);
- biological factors (pathogenic microorganisms also animals and plants)
- psychophysiological  factors  (factors  of  the  labor  process:  mental  stress,
monotony of work, emotional overload)
The  main  elements  of  the  production  process  that  form  dangerous  and
harmful factors are presented in Table 19.



















Organizations of Education and
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GOST 12.2.032-78 Occupational
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location in a sitting position.
General ergonomic requirements








value in the circuit, the
closure which may occur
through the human body
+ +
Sanitary rules GOST 12.1.038-82
Occupational safety standards
system. Electrical safety




NRB- 99/2009. Sanitary rules and
regulations 2.6.1.2523-09
The following factors effect on person working on a computer:
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- physical: temperature and humidity, noise, static electricity, electromagnetic
field of low purity, illumination;
- psychophysiological:  psychophysiological  dangerous  and  harmful  factors
are  divided  into:  physical  overload  (static,  dynamic)  and  mental  stress  (mental
overstrain, monotony of work, emotional overload).
6.4.2.1 Deviation of microclimate indicators
The air of the working area (microclimate) is determined by the following
parameters: temperature, relative humidity, air speed. The optimum and permissible
values of the microclimate characteristics are established in accordance with [43] and
are given in Table 20.
Table 20 - Optimal and permissible parameters of the microclimate
Period of the year Temperature,℃ Relative humidity,% Speed of air
movement, m/s
Cold and changing of
seasons
23 – 25 40 – 60 0.1
Warm 23 – 25 40 0.1
6.4.2.2 Excessive noise
Noise and vibration worsen working conditions, have a harmful effect on the
human body, namely, the organs of hearing and the whole body through the central
nervous  system.  It  result  in  weakened  attention,  deteriorated  memory,  decreased
response,  and  increased  number  of  errors  in  work.  Noise  can  be  generated  by
operating equipment, air conditioning units, daylight illuminating devices, as well as
spread from the outside. When working on a PC, the noise level in the workplace
should not exceed 50 dB.
6.4.2.3 Increased level of electromagnetic radiation
The screen and system blocks produce electromagnetic radiation.  Its  main
part comes from the system unit and the video cable. According to [43], the intensity
of  the  electromagnetic  field  at  a  distance  of  50  cm around the  screen  along the
electrical component should be no more than:
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- in the frequency range 5 Hz – 2 kHz – 25 V/m;
- in the frequency range 2 kHz – 400 kHz – 2.5 V/m.
The magnetic flux density should be no more than:
- in the frequency range 5 Hz – 2 kHz – 250 nT;
- in the frequency range 2 kHz – 400 kHz – 25 nT.
6.4.2.4 Abnormally high voltage value in the circuit
Depending on the conditions in the room, the risk of electric shock to a person
increases or decreases.  Do not operate the electronic device in conditions of high
humidity (relative air humidity exceeds 75% for a long time), high temperature (more
than 35 ℃), the presence of conductive dust, conductive floors and the possibility of
simultaneous contact with metal components connected to the ground and the metal
casing  of  electrical  equipment.  The  operator  works  with  electrical  devices:  a
computer (display, system unit, etc.) and peripheral devices. There is a risk of electric
shock in the following cases:
- with direct contact with current-carrying parts during computer repair;
- when touched by non-live parts that are under voltage (in case of violation
of insulation of current-carrying parts of the computer);
- when touched with the floor, walls that are under voltage;
- short-circuited in high-voltage units: power supply and display unit.
Table 21 presents upper limits for values of contact current and voltage.
Table 21– Upper limits for values of contact current and voltage
Voltage, V Current, mA
Alternate, 50 Hz 2 0.3
Alternate, 400 Hz 3 0.4
Direct 8 1.0
6.4.2.5 Insufficient illumination of the working area
According to the standard, the illumination on the table surface in the area of
the working document should be 300-500 lux. Lighting should not create glare on the
surface of the monitor. Illumination of the monitor surface should not be more than
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300 lux.
The brightness of the lamps of common light in the area with radiation angles
from 50 to 90° should be no more than 200 cd/m, the protective angle of the lamps
should  be  at  least  40°.  The  safety  factor  for  lamps  of  common  light  should  be
assumed to be 1.4. The ripple coefficient should not exceed 5%.
6.4.2.6 Increased levels of ionizing radiation
Ionizing radiation is radiation that could ionize molecules and atoms. This
effect is widely used in energetics and industry. However, there is health hazard. In
living tissue,  this radiation could damage cells that result  in two types of effects.
Deterministic effects (harmful tissue reactions) due to exposure with high doses and
stochastic effects due to DNA destruction and mutations (for example, induction of
cancer).
To provide radiation safety with using sources of ionizing radiation one must
use next principles:
- keep individual radiation doses from all radiation sources not higher than
permissible exposure;
- forbid all activity with using radiation sources if profit is low than risk of
possible hazard;
- keep  individual  radiation  doses  from  all  radiation  sources  as  low  as
possible.
According to NRB-99/2009[44], there are  three groups of people related to
work with radiation: 
- Personnel A – personnel who work directly with radiation sources.
- Personnel B – personnel who do not directly work with radiation sources,
but are exposed to them.
- Population. 
Table 71 shows dose limits for all three groups of people. 
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20 mSv per year in average
during 5 years, but not
higher than 50 mSv per year
1 mSv per year in average
during 5 years, but not
higher than 5 mSv per year
Equivalent dose 
per year
Eye’s lens 150 mSv 15 mSv
Skin 500 mSv 50 mSv
Hands and feet 500 mSv 50 mSv
* Dose limits for personnel B are quarter part of dose limits of stuff A.
In addition, for women from personnel of age below 45 years there is limit of
1 mSv per month of equivalent dose on lower abdomen. During gestation and breast
feeding women must not work with radiation sources.
6.4.3  Justification  of  measures  to  reduce  the  levels  of  exposure  to
hazardous and harmful factors on the researcher
6.4.3.1 Deviation of microclimate indicators
The  measures  for  improving  the  air  environment  in  the  production  room
include: the correct organization of ventilation and air conditioning, heating of room.
Ventilation can be realized naturally and mechanically. In the room, the following
volumes of outside air must be delivered: 
- at least 30 m3 per hour per person for the volume of the room up to 20 m3
per person;
- natural  ventilation is  allowed for  the volume of  the room more than 40
m3per person and if there is no emission of harmful substances.
The heating system must provide sufficient, constant and uniform heating of
the air. Water heating should be used in rooms with increased requirements for clean
air. 
The parameters of the microclimate in the laboratory regulated by the central
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heating system, have the following values: humidity 40%, air speed 0.1 m/s, summer
temperature  20-25  ℃,  in  winter  13-15  ℃.  Natural  ventilation  is  provided  in  the
laboratory.  Air  enters  and  leaves  through  the  cracks,  windows,  doors.  The  main
disadvantage  of  such  ventilation  is  that  the  fresh  air  enters  the  room  without
preliminary cleaning and heating.
6.4.3.2 Excessive noise
In this paper, the source of the noise can be either radiation therapy equipment
or computers. If the maximum permissible conditions are exceeded, it is sufficient to
use  sound-absorbing  materials  in  the  room  (sound-absorbing  wall  and  ceiling
cladding, window curtains).  To reduce the noise penetrating outside the premises,
install seals around the perimeter of the doors and windows.
6.4.3.3 Increased level of electromagnetic radiation
There are the following ways to protect against electromagnetic radiation:
- increase the distance from the source (the screen should be at least 50 cm
from the user);
- the use of pre-screen filters, special screens and other personal protective
equipment.
Fatigue  of  the  organs  of  vision  can  be  associated  with  both  insufficient
illumination and excessive illumination, as well as with the wrong direction of light.
6.4.3.4 Abnormally high voltage value in the circuit
To ensure the safety of work in electrical installations, next steps should be
performed [45]:
- disconnecting  the  installation  (part  of  the  installation)  from  the  power
source;
- checking the absence of voltage;
- mechanical locking of the drives of switching devices, removal of fuses,
disconnection  of  the  ends  of  supply  lines  and  other  measures  that  exclude  the
possibility of erroneous supply of voltage to the place of work;
- grounding  of  disconnected  live  parts  (application  of  portable  earthing
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switches, switching on of grounding knives);
- fencing of the workplace or live parts that remain under voltage, which can
be touched or approached to an unacceptable distance during operation.
6.4.3.5 Insufficient illumination of the working area
Light sources can be both natural and artificial. The natural source of the light
in the room is the sun, artificial light are lamps. With long work in low illumination
conditions and in violation of other parameters of the illumination, visual perception
decreases, myopia, eye disease develops, and headaches appear.
Desktops  should  be  placed  in  such  a  way  that  the  monitors  are  oriented
sideways to the light openings, so that natural light falls mainly on the left.
Also, as a means of protection to minimize the impact of the factor,  local
lighting should be installed due to insufficient lighting, window openings should be
equipped with adjustable devices such as blinds, curtains, external visors, etc.
6.4.2.6 Increased levels of ionizing radiation
In case of radiation accident, responsible personnel must take all measures to
restore control of radiation sources and reduce to minimum radiation doses, number
of irradiated persons, radioactive pollution of the environment, economic and social
losses caused with radioactive pollution.
Radiation control is a main part of radiation safety and radiation protection. It
is aimed at not exceeding the established basic dose limits and permissible levels of
radiation,  obtaining the  necessary  information to  optimize  protection  and making
decisions about interference in the case of radiation accidents, contamination of the
environment and buildings with radionuclides.
The radiation control is control of:
- radiation characteristics  of  radiation sources,  pollution  in  air,  liquid and
solid wastes;
- radiation factors developed with technological processes in working places
and environment;
- radiation factors of contaminated environment;
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- irradiation dose levels of personnel and population.
The main controlled parameters are:
- annual effective and equivalent doses;
- intake and body content of radionuclides;
- volume or specific activity of radionuclides in air,  water,  food products,
building materials and etc;
- radioactive contamination of skin,  clothes,  footwear, working places and
etc;
- dose and power of external irradiation;
- particles and photons flux density.
Radiation  protection  office  establish  control  levels  of  all  controlled
parameters in according to not exceed dose limits and keep dose levels as low as
possible.  In  case  of  exceeding  control  levels  radiation  protection  officers  start
investigation of exceed causes and take actions to eliminate this exceeding.
During planning and implementation of radiation safety precautions, taking
any actions about radiation safety and analysis of effectiveness of mentioned action
and precautions one must value radiation safety with next factors:
- characteristics of radioactive contamination of the environment;
- probability of radiation accidents and scale of accidents;
- degree of readiness to effective elimination of radiation accidents and its
aftermathches; 
- number of  persons irradiated with doses higher than controlled limits of
doses;
- analysis  of  actions  for  providing radiation  safety,  meeting  requirements,
rules, standards of radiation safety;




Sources  of  ionizing radiation  used in  medicine  could  be  divided into  two
groups:  radioactive  substances  and  radiation  generators.  The  difference  is  that
radiation generators  like accelerators and x-ray tubes emit  ionizing radiation only
when they are turned on.  
In ordinary work with necessary safety precautions,  there  are insignificant
impact of using sources of ionizing radiation on environment. The immediate effect
of  ionizing  radiation  is  ionization  of  air  in  room,  but  after  a  specified  time  the
ionization disappears.
For  the  implementation  of  the  work,  special  therapeutic  installations  of
radiation therapy are required. Two types of equipment can be used, the first of which
is an electron accelerator. Electron accelerators represent radiation generators which
can be turn off and turn on of necessity. The danger of such in devices is minimized
and work on such equipment does not have a significant impact on the environment.
The second type of equipment, it is device with a radioactive source. In case
of using radioactive materials, the danger could occur only in accidents with stealing
and loosing such materials due to high radioactivity.
6.6 Safety in emergency
6.6.1 Analysis of probable emergencies that may occur at the workplace 
during research
6.6.1.1 Fire safety
According to  the explosion and fire  hazard,  the premises  are  divided into
groups A, B, C,G, D (from A to D to reduce the hazard). A room with a personal
computer  belongs  to  category B.  This  group includes  [46] flammable  and hardly
combustible  liquids,  solid  combustible  and  hardly  combustible  substances  and
materials (including dust and fibers), substances and materials capable of interacting
with water, air oxygen or only burn with each other.
Possible causes of fire include:
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- short circuit in the power supply unit;
- work with uncovered electrical equipment or with equipment that does not
have adequate insulation;
- malfunction of live parts of the electrical installation;
- non-observance of the rules for the safe operation of equipment;
- presence of flammable or combustible substances in the immediate vicinity
of the electrical installation (paper, cables, etc.).
In connection with the possibility of fire hazardous situations, it is necessary
to  carry  out  preventive  measures  aimed  at  fire  safety:  organizational,  technical,
regime and operational.
To prevent fire from short circuits, overloads, etc., the following fire safety
rules must be observed:
- elimination  of  the  formation  of  a  flammable  environment  (sealing
equipment, control of the air, working and emergency ventilation);
- use in the construction and decoration of buildings of non-combustible or
difficultly combustible materials;
- the correct operation of the equipment (proper inclusion of equipment in the
electrical supply network, monitoring of heating equipment);
- correct maintenance of buildings and territories (exclusion of the source of
ignition  -  prevention of  spontaneous  combustion  of  substances,  restriction  of  fire
works);
- training of production personnel in fire safety rules;
- the publication of instructions, posters, the existence of an evacuation plan;
- compliance with fire regulations, norms in the design of buildings, in the
organization of electrical wires and equipment, heating, ventilation, lighting;
- the correct placement of equipment;
- well-time preventive inspection, repair and testing of equipment.
In the case of an emergency, it is necessary to:
- inform the management (duty officer, if it is not an apartment or a private
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house);
- call  the  Emergency  Service  or  the  Ministry  of  Emergency  Situations  -
tel.112;
- take measures to eliminate the accident in accordance with the instructions.
6.7 Conclusions
In this section about social responsibility the hazardous and harmful factors
were revealed. All necessary safety measures and precaution to minimize probability
of accidents and traumas during investigation are given. 
The possible negative impact on the environment due to the study has been
considered and is not significant.
It  could  be  stated  that  with  respect  to  all  regulations  and  standards,




In this work the effectiveness of radiation therapy for head-and-neck tumors
was  analyzed.  According  to  the  literature  review,  the  implemented  conventional
mode leads to good control of the tumor in a relatively short period of time (3-year
locoregional control is about 70 %), while not conventional fractionation of radiation
therapy leads to better control results in the long term: 5-year locoregional control for
conventional mode is around 50 %, for accelerated, hypo- and hyperfractionation is
more than 60 %. 
Also the study presents predictions of the treatment results of 16 patients who
received treatment in Tomsk, in the Tomsk Regional Oncology Center, and Tyumen,
in the Tyumen Regional Oncological Dispensary, based on the resources analyzed in
the  literature  review.  In  both  cases,  the  data  from  the  cumulative  DVH  were
transformed into differential, with subsequent calculation of EUD, TCP and NTCP.
Since the method of calculating control in the literature review sources and
for current patients is not the same, there is a difference in control. Patients who were
analyzed, mainly, were treated with conventional fractionation mode, i.e. 2 Gy per
fraction up to 70 Gy to tumor. And also most of the researches in literature review
describe  results  of  the  same  fractionation  mode.  It  allows  to  suppose  that,  in
generally, 3-year locoregional control and 5-year locoregional control are in range of
65 – 75 % and 40 – 50 % respectively for conventional mode. 
Patients with SIB (simultaneously integrated boost) has bigger TCP values
control with the same EUD as patient who treated with conventional radiation mode.
However, based on literature review it is difficult to draw conclusion because of lack
on studies and different values of total dose.
For  critical  organs,  late  complications  are  not  observed,  however,  early
complications, depending on the area of irradiation, have 3 – 4 grade of severity.
Based on the results obtained, it can be saying that there is a need to revise the
treatment of head-and-neck tumors, at least for the later stages of tumor development.
For control at least 70 %, 70 – 71 Gy of EUD is minimum dose which should
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be delivered to patient with stages III and IV when conventional mode is used. On the
other hand, for some sites such as oropharynx, oral cavity, including tongue, this dose
will not lead to satisfied results. Escalation of total dose causes increasing of normal
tissue irradiation, therefore, this treatment option should be considered in the absence
of other options. Alternatively, to improve tumor control, hypo- or hyperfractionation
can be used, which implies a decrease in the duration of treatment and an increase in
tumor control  by decreasing the  TD50.  With the same total  dose as in the classic
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Treatment EQD2, Gy Locoregional control (LRC)
1
Montejo, M. E., 




IMRT-SIB 67.5 Gy, 60.0 Gy (30
fractions)
EQD2(67.5 Gy, 2.25
Gy) = 68.9 Gy
LRC 5 years – 82%
2
Widder, J., 





Accelerated mode, 64 – 66 Gy (4
weeks )
EQD2(36 Gy, 1.8 Gy) = 35.4 Gy,
EQD2(30 Gy, 
1.45 Gy) =28.6 Gy,
EQD2 = 64 Gy
LRC 3 years – 55%
3
Numico, G., 
Russi, E. G. et al.[20]
IV, squamous cell
carcinoma
+ 66 Gy (33 fractions) -
LRC 3 years – 64 %, 
5 years – 56 %
4
Rabbani, A., 




+ 70 Gy (35 fractions) - LRC 3 years– 78 %
5
Newlin, H. E., 




IMRT, hyperfractionted mode – 72 Gy
(42 fractions), 74.4 Gy (62 fractions)
EQD2(72 Gy, 1.7 Gy) = 70.2 Gy,
EQD2(74.4 Gy,
1.2 Gy) = 69.4 Gy
LRC 5 years – 79%
6
Rumley, C. N., 
Nedev, N. et al.[23]
III, IV, squamous
cell carcinoma
+ IMRT, 66 Gy (30 fractions) EQD2(66 Gy, 2.2 Gy) = 67.1 Gy LRC 3 years – 87.3 %
7
Huang, S. H., 





Chemoradiotherapy, classic mode 70 Gy
(35 fractions) , hypofractionted mode 60
Gy (25 fractions)
EQD2(60 Gy, 2.4 Gy) = 62 Gy
LRC 3 years – 93.3 %
(Chemoradiotherapy), 85.7 %




Rühle, A. et al.[25]
III, IV, squamous
cell carcinoma
+ 3D CRT, IMRT – 70 Gy (35 fractions) - LRC 3 years – 74%
9
Katsoulakis, E., 
Riaz, N. et al.[26]
II, III, IV, squamous
cell carcinoma
+
3D CRT 70 Gy (35 fractions), IMRT 70
Gy ( 33 fractions) 
EQD2(70 Gy,
2.12 Gy) = 70.7 Gy




Alfonsi, M. et al. [27]
III, IV, squamous
cell carcinoma
+ 70 Gy (35 fractions) -








Treatment EQD2, Gy Locoregional control (LRC)
11
Denis, F., 
Garaud, P. et al.[28] 
III, IV, squamous
cell carcinoma
+ 70 Gy (35 fractions) -




Regine, W. F., 




Accelerated mode, 76.8–79.2 Gy (1.2
Gy, 6 – 7 weeks) 
EQD2(76.8 Gy,
1.2 Gy) = 71.7 Gy ,
EQD2(79.2 Gy,
1.2 Gy) = 73.9 Gy





Jensen, A. D. et al.[30]
III, IV, squamous
cell carcinoma
+ IMRT 69.9 Gy (6 weeks)
EQD2(50.4 Gy,
1.8 Gy) = 49.6 Gy,
EQD2(19.5 Gy,
1.5 Gy) = 18.7 Gy,
EQD2 = 68.3 Gy
LRC 3 years – 71%
14




+ 3D CRT, IMRT 70 Gy (35 fractions) -









+ 70 Gy (35 fractions) - LRC 3 years – 70 %
16
Horiot, J. C., 





Accelerated mode – 72 Gy (45 fractions,
5 weeks), classic mode – 70 Gy (35
fractions, 7 weeks), 
EQD2(72 Gy, 1.6 Gy) = 69.6 Gy
LRC 5 year – 59 %(accelerated
mode), 46% (conventional mode) 
17
Poulsen, M. G., 





Accelerated mode – 59.4 Gy
(33 fractions, 3.5 weeks), classic mode –
70 Gy (35 fractions, 7 weeks),
EQD2(59.4 Gy,
1.8 Gy) = 58.4 Gy
LRC 5 year – 52 %(accelerated
mode), 47% (conventional mode)
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Appendix B
Example of  integral DVH from Eclipse software
Patient Name         :  
Patient ID              : 
Comment              : DVHs for one plan
Date                      : 
Exported by          : 
Type                     : Cumulative Dose Volume Histogram
Description          : The cumulative DVH displays the percentage (relative)
                            or volume (absolute) of structures that receive a dose
                            equal to or greater than a given dose.
Plan: Boost
Course: VMAT
Plan Status: Treatment Approved 
Total dose [Gy]: 10.000








Min Dose [Gy]: 0.057
Max Dose [Gy]: 10.632
Mean Dose [Gy]: 1.631
Modal Dose [Gy]: 0.106
Median Dose [Gy]: 0.820
STD [Gy]: 1.906
Equiv. Sphere Diam. [cm]: 13.8
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Conformity Index: N/A
Gradient Measure [cm]: N/A
















        Dose [Gy]   Relative dose [%] Ratio of Total Structure Volume [%]
                0                   0                       100
              0.1                   1                   93.8889
              0.2                   2                   72.8406
              0.3                   3                     63.51
              0.4                   4                   58.7395
              0.5                   5                   55.7221
/.../
             10                 100                     0.526663
             10.1                 101                  0.432565
             10.2                 102                  0.327042
             10.3                 103                  0.198939
             10.4                 104                 0.0795901
             10.5                 105                 0.0157932
             10.6                 106               9.9537e-005
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             10.7                 107                         0








Min Dose [Gy]: 8.621
Max Dose [Gy]: 10.868
Mean Dose [Gy]: 10.346
Modal Dose [Gy]: 10.400
Median Dose [Gy]: 10.378
STD [Gy]: 0.179
Equiv. Sphere Diam. [cm]: 4.9
Conformity Index: 1.24
Gradient Measure [cm]: 1.28

















        Dose [Gy]   Relative dose [%] Ratio of Total Structure Volume [%]
                0                   0                       100
              0.1                   1                       100
              0.2                   2                       100
              0.3                   3                       100
              0.4                   4                       100
/.../
              8.5                  85                       100
              8.6                  86                       100
              8.7                  87                   99.9999
              8.8                  88                   99.9993
              8.9                  89                   99.9968
                9                  90                   99.9887
              9.1                  91                   99.9719
/.../
             10.6                 106                   2.36472
             10.7                 107                  0.200784
             10.8                 108                0.00780836
Example of differential DVH from Monaco software
Patient ID: 40~TM20208468 |  Plan Name: PTV60 |  Resolution: 0.10(cm) |  Bin Width:
0.010(Gy) | Dose Units: Gy | Volume Units: %
Structure Name |                     Dose |                     Volume
Brainstem                    0.000                    0.000
Brainstem                    0.605                    0.000
Brainstem                    0.615                    0.007
Brainstem                    0.625                    0.007
Brainstem                    0.635                    0.027
/.../
Brainstem                    15.895                    0.000
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Brainstem                    15.905                    0.003
Brainstem                    15.915                    0.000
Brainstem                    66.645                    0.000
Brainstem                    66.650                    0.000
/.../
PTV60                    0.000                    0.000
PTV60                    52.205                    0.000
PTV60                    52.215                    0.001
PTV60                    52.225                    0.000
PTV60                    52.375                    0.000
PTV60                    52.385                    0.001
PTV60                    52.395                    0.000
/.../
PTV60                    66.435                    0.000
PTV60                    66.475                    0.000
PTV60                    66.485                    0.001
PTV60                    66.495                    0.000
PTV60                    66.635                    0.000
PTV60                    66.645                    0.001
PTV60                    66.650                    0.001
Spinal_Cord                    0.000                    0.000
Spinal_Cord                    0.005                    0.000
Spinal_Cord                    0.015                    0.006
Spinal_Cord                    0.025                    2.043
Spinal_Cord                    0.035                    6.515
Spinal_Cord                    0.045                    7.251
/.../
Spinal_Cord                    7.645                    0.000
Spinal_Cord                    7.695                    0.000
Spinal_Cord                    7.705                    0.004
Spinal_Cord                    7.715                    0.000
Spinal_Cord                    66.645                    0.000
Spinal_Cord                    66.650                    0.000
Thyroid_Gland                   0.000                    0.000
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Thyroid_Gland                    0.225                    0.000
Thyroid_Gland                    0.235                    0.060
Thyroid_Gland                    0.245                    0.181
Thyroid_Gland                    0.255                    0.377
Thyroid_Gland                    0.265                    0.603
/.../
Thyroid_Gland                    0.895                    0.000
Thyroid_Gland                    0.905                    0.015
Thyroid_Gland                    0.915                    0.000
Thyroid_Gland                    66.645                    0.000
Thyroid_Gland                    66.650                    0.000
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Appendix C
Table C.1 – Parameters for EUD and NTCP calculations
Structure α γ50 TD50, Gy Structure α γ50 TD50, Gy
Brain [37] 5 3 60 Thyroid gland [40] 0.92 1.05 44.3
Brainstem [37] 7 3 65 Parotid gland [39] 0.5 2.2 28.4
Esophagus [37] 19 4 68 Lung [37] 1 2 24.5
Spinal cord[38] 7 4 66.5 Larynx [38] 12.5 4 70
Mandible [39] 14 4 72 Cochlea [41] 1 1.27 46.3
Table C.2 – Obtained EUD and NTCP for all patients
№
Structures




Lungs Parotid gland Larynx Cochlea
L R L R L R
Patient 1
EUD, Gy - 9.49 0.43 0.44 4.67 44.53 - - - - - - -
NTCP - 9.38·10-11 7.47·10-36 3.83·10-9 3.51·10-19 4.59·10-4 - - - - - - -
Patient 2
EUD, Gy - 19.12 45.54 - 30.73 59.57 2.16 2.16 - - - - -





- - - - -
Patient 3
EUD, Gy - 18.27 44.24 - 26.53 53.13 1.14 40.94 43.54 - - -
NTCP - 2.44·10-7 1.03·10-3 - 4.11·10-7 7.67·10-3 2.18·10-11 9.62·10-1 9.77·10-1 - - -
Patient 4

















Continuation of Table C.2
№
Structures







L R L R L R
Patient 5
EUD, Gy - 24.59 27.50 - 20.55 56.59 0.59 - - - - -
NTCP - 8.61·10-6 5.11·10-7 - 6.90·10-9 2.08·10-2 1.11·10-13 - - - - -
Patient 6
EUD, Gy - - 44.50 - 30.29 50.43 2.59 33.07 21.23 - - -
NTCP - - 1.13·10-3 - 3.43·10-6 3.35·10-3 1.56·10-8 7.92·10-1 7.17·10-2 - - -
Patient 7
EUD, Gy - 15.64 39.46 - 26.14 52.83 1.37 30.90 33.64 - - -
NTCP - 3.77·10-8 1.66·10-4 - 3.25·10-7 7.01·10-3 9.34·10-11 6.77·10-1 8.16·10-1 - - -
Patient 8
EUD, Gy - 27.54 44.14 - 33.95 59.18 - - 34.18 35.43 - - -
NTCP - 3.35·10-5 9.93·10-4 - 2.13·10-5 4.15·10-2 - - 8.36·10-1 8.75·10-1 - - -
Patient 9
EUD, Gy - 12.96 34.46 - - 56.00 - - 18.03 17.85 44.16 5.53 10.34
















1.20·10-4 5.53·10-5 - - -
Patient 11
EUD, Gy 16.22 - - - - 56.17
10.2
9









- - - - -
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Continuation of Table C.2
№
Structures







L R L R L R
Patient 12
EUD, Gy - - 63.50 66.90 36.14 - 11.42 7.27 8.99 - - -
NTCP - - 2.50·10-1 8.50·10-1 5.79·10-5 - 2.23·10-3 6.19·10-6 4.03·10-5 - - -
Patient 13












- - - - -
Patient 14
EUD, Gy - 14.45 44.65 - 25.03 46.57 2.64 2.31 33.48 39.98 - - -





8.10·10-1 9.53·10-1 - - -
Patient 15




- - - 1.03·10-7 - - - 2.93·10-2 6.46·10-2 - - -
Patient 16




- - - 3.07·10-7 - - - 3.73·10-2 3.81·10-2 - - -
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